These previous observations, and our results, suggest that p21CIP1 might not be a useful senescence-associated marker in the evaluation of TIS in invasive breast cancer due to its variable expression following exposure to DNA damaging NAC. The gene discussed is CDKN1A; the disease is invasive breast carcinoma.